| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |